Association between stress hyperglycemia ratio and all-cause mortality in patients with acute kidney injury: a retrospective analysis of the MIMIC-IV database using machine learning

应激性高血糖比值与急性肾损伤患者全因死亡率之间的关联:基于机器学习的MIMIC-IV数据库回顾性分析

阅读:1

Abstract

BACKGROUND: The stress hyperglycemia ratio (SHR) reflects relative hyperglycemia levels. Prior studies indicate that SHR is related to the prognosis of certain diseases. This study investigated the predictive accuracy of SHR for in-hospital and intensive care unit (ICU) mortality in acute kidney injury (AKI) patients. METHODS: We analyzed 4,418 AKI patients from the Medical Information Mart for Intensive Care (MIMIC-IV) database. SHR was calculated as admission blood glucose (mg/dl) divided by (28.7 × HbA1c(%) − 46.7). Patients were stratified into four groups based on SHR levels. Restricted cubic splines (RCS) and Cox proportional hazards models were employed to assess the association between SHR and mortality, and Kaplan-Meier survival analysis was conducted to compare mortality rates stratified by SHR groups. Subgroup analyses evaluated the consistency of these associations across clinically relevant populations. Machine learning algorithms (Boruta feature selection, logistic regression, random forest) were employed to build predictive models. RESULTS: Among 4,418 patients (36.03% female), in-hospital and ICU mortality rates were 6.88% and 4.48%, respectively. A U-shaped relationship was observed between SHR and mortality (nonlinear p = 0.015 for in-hospital, p = 0.048 for ICU mortality). Kaplan-Meier analysis revealed significant survival differences across SHR groups (log-rank p < 0.01). Cox regression showed that each unit increase in SHR was associated with 23% higher in-hospital mortality (HR = 1.23, 95% CI: 1.09–1.40) and 47% higher ICU mortality (HR = 1.47, 95% CI: 1.25–1.74). Machine learning models achieved AUCs of 0.76–0.77 for mortality prediction. CONCLUSIONS: In critically ill AKI patients, higher SHR is associated with increased mortality after adjustment for key covariates. However, its modest standalone discriminative capacity indicates that SHR is best combined with other clinical variables rather than used alone. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-025-04523-3.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。